Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 2, Pages 174
Publisher
MDPI AG
Online
2019-02-06
DOI
10.3390/cancers11020174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor treating fields: a new approach to glioblastoma therapy
- (2018) Jonathan Rick et al. JOURNAL OF NEURO-ONCOLOGY
- Tumor-Treating Fields
- (2018) Lia M. Halasz et al. JAMA Oncology
- Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma
- (2018) Martin J. B. Taphoorn et al. JAMA Oncology
- Abstract LB-257: Tumor treating fields treatment for patients with newly diagnosed glioblastoma: A cost-effectiveness analysis
- (2018) Gregory F. Guzauskas et al. CANCER RESEARCH
- Safety of tumor treating fields and concomitant radiotherapy for newly diagnosed glioblastoma.
- (2018) Rachel Grossman et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus
- (2018) Joshua D. Palmer et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of Tumor Treating Fields (TTFields) on Health-Related Quality of Life (HRQOL) in Newly Diagnosed Glioblastoma: An Exploratory Analysis of the EF-14 Randomized Phase III Trial
- (2018) S.A. Toms INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Analysis of RTOG-RPA Scores in the Phase 3 EF-14 Trial of Tumor Treating Fields with Temozolomide (TTFields/TMZ) Versus TMZ Alone in Newly Diagnosed Glioblastoma.
- (2018) K. Choe INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
- (2018) S. A. Toms et al. JOURNAL OF NEURO-ONCOLOGY
- AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
- (2018) Anna Shteingauz et al. Cell Death & Disease
- The cost and value of glioblastoma therapy
- (2017) Daniel N. Cagney et al. Expert Review of Anticancer Therapy
- A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma
- (2017) George Shenouda et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
- (2017) Prakash Chinnaiyan et al. NEURO-ONCOLOGY
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- TTFields: where does all the skepticism come from?
- (2016) Wolfgang Wick NEURO-ONCOLOGY
- The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
- (2016) F. Bernard-Arnoux et al. NEURO-ONCOLOGY
- Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit
- (2015) Nidhi Gera et al. PLoS One
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe)
- (2014) Maciej M. Mrugala et al. SEMINARS IN ONCOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started